Close Menu

NEW YORK (GenomeWeb) – Cell detection and liquid biopsy firm RareCyte said today that it has raised $30 million in a private financing round, which it plans to use to advance commercial sales efforts and build new companion diagnostic partnerships.

The investment was led by 5AM Ventures with additional participation from existing investors including Telegraph Hill Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Researchers have identified a gene involved in how people determine when to urinate.

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.